These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35073829)

  • 1. Descriptor-free QSAR: effectiveness in screening for putative inhibitors of FGFR1.
    Joel IY; Sulaimon LA; Idris MO; Adigun TO; Adisa RA; Ademoye TA; Ogunleye MO; Olaniyi TO
    J Biomol Struct Dyn; 2023 Mar; 41(5):2016-2032. PubMed ID: 35073829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR, docking and molecular dynamics simulations of novel Pyrazolo-pyridazinone derivatives as covalent inhibitors of FGFR1: a scientific approach for possible anticancer agents.
    Hamza S; Abid A; Khanum A; Chohan TA; Saleem H; Maqbool Khan K; Khurshid U; Butt J; Anwar S; Alafnan A; Ansari SA; Qayyum A; Raza A; Chohan TA
    J Biomol Struct Dyn; 2024 Mar; 42(5):2242-2256. PubMed ID: 37211823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
    Kashyap K; Kakkar R
    J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of pyrrolo-pyrimidine based analogs as potential FGFR1 inhibitors: a scientific approach for therapeutic drugs.
    Raza A; Chohan TA; Sarfraz M; Chohan TA; Imran Sajid M; Tiwari RK; Ansari SA; Alkahtani HM; Yasmeen Ansari S; Khurshid U; Saleem H
    J Biomol Struct Dyn; 2023; 41(23):14358-14371. PubMed ID: 36898855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
    Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors.
    Huang L; Wu X; Fu X; Wang H; Tang B; Xiao Y; Zhou C; Zhao Z; Wan Y; Chen H; Tang Z; Yao H; Shan Z; Bu T
    J Biomol Struct Dyn; 2022 Oct; 40(16):7584-7597. PubMed ID: 33734039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.
    Simeon S; Jongkon N; Chotpatiwetchkul W; Gleeson MP
    J Comput Aided Mol Des; 2019 Aug; 33(8):745-757. PubMed ID: 31494804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential FAK inhibitors using mol2vec molecular descriptor-based QSAR, molecular docking, ADMET study, and molecular dynamics simulation.
    Hang NT; My TTK; Van Anh LT; Van Anh PT; Anh TDH; Van Phuong N
    Mol Divers; 2024 Apr; ():. PubMed ID: 38582821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated machine learning, molecular docking and 3D-QSAR based approach for identification of potential inhibitors of trypanosomal N-myristoyltransferase.
    Singh N; Shah P; Dwivedi H; Mishra S; Tripathi R; Sahasrabuddhe AA; Siddiqi MI
    Mol Biosyst; 2016 Nov; 12(12):3711-3723. PubMed ID: 27766319
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR study of tetrahydropteridin derivatives as polo-like kinase 1(PLK1) Inhibitors with molecular docking and dynamics study.
    Garima ; Sharma S; Sindhu J; Kumar P
    SAR QSAR Environ Res; 2023 Feb; 34(2):91-116. PubMed ID: 36744430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
    El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.